| Literature DB >> 22855753 |
Matthew Burns, Mark Rowland, Raphael N'Guessan, Ilona Carneiro, Arlyne Beeche, Stefani Sesler Ruiz, Sarian Kamara, Willem Takken, Pierre Carnevale, Richard Allan.
Abstract
A double-blind phase III malaria prevention trial was conducted in two refugee camps using pre-manufactured insecticide-treated plastic sheeting (ITPS) or untreated polyethylene sheeting (UPS) randomly deployed to defined sectors of each camp. In Largo camp the ITPS or UPS was attached to inner walls and ceilings of shelters, whereas in Tobanda the ITPS or UPS was used to line only the ceiling and roof. In Largo the Plasmodium falciparum incidence rate in children up to 3 years of age who were cleared of parasites and monitored for 8 months was 163/100 person-years under UPS and 63 under ITPS (adjusted odds ratio [AOR] = 0.40, 95% confidence interval [CI] = 0.33-0.47). In Tobanda incidence was 157/100 person-years under UPS and 134 under ITPS (AOR = 0.85, 95% CI = 0.75-0.95). Protective efficacy was 61% under fully lined ITPS and 15% under roof lined ITPS. Anemia rates improved under ITPS in both camps. This novel tool proved to be a convenient, safe, and long-lasting method of malaria control when used as a full shelter lining in an emergency setting.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22855753 PMCID: PMC3414558 DOI: 10.4269/ajtmh.2012.11-0744
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345
Figure 1.Map of Sierra Leone indicating evaluation sites and entry points of refugees from Liberia (dashed arrows).
Figure 2.Largo (plots fully lined with polyethylene sheeting) and Tobanda (plot roof only covering with polyethylene sheeting). Refugee camps with intervention, control, and respective buffer section demarcation. Section information in parentheses refers to the maximum number of shelters (S) and latrines (L) that were planned for under initial camp design planning.
Figure 3.Study profile of child cohort (4–36 months) entered into longitudinal monitoring.
Cross-sectional population survey of Plasmodium falciparum prevalence in samples of the refugee populations after the camps were fully established and before the longitudinal monitoring of the child cohorts*
| Largo (full shelter coverage) | % Positive | (No. pos/total) | OR | 95% CI | AOR | 95% CI | ||
|---|---|---|---|---|---|---|---|---|
| Treatment | UPS | 58.2 | (248/426) | 1 | 1 | |||
| ITPS | 48.9 | (198/405) | 0.68 | (0.52, 0.90) | 0.57 | (0.41, 0.78) | 0.001 | |
| Age group | < 5 y | 73.8 | (183/248) | 1 | 1 | |||
| 5–9 y | 86.1 | (105/122) | 2.21 | (1.23, 3.98) | 2.21 | (1.23, 3.98) | 0.008 | |
| 10–14 y | 69.7 | (46/66) | 0.87 | (0.47, 1.58) | 0.87 | (0.48, 1.60) | 0.66 | |
| > 14 y | 28.1 | (110/391) | 0.13 | (0.09, 0.19) | 0.13 | (0.09, 0.19) | 0.0001 | |
| Gender | Male | 59.3 | (192/324) | 1 | 1 | |||
| Female | 50.3 | (254/505) | 0.70 | (0.53, 0.93) | 1.01 | (0.72, 1.40) | 0.97 | |
| Tobanda (ceiling/roof coverage) | % positive | (No. pos/total) | OR | 95% CI | AOR | 95% CI | ||
| Treatment | UPS | 44.4 | (186/419) | 1 | 1 | |||
| ITPS | 46.9 | (169/360) | 1.11 | (0.84, 1.47) | 1.09 | (0.80, 1.48) | 0.59 | |
| Age group | < 5 y | 56.5 | (135/239) | 1 | 1 | |||
| 5–9 y | 73.9 | (105/142) | 2.19 | (1.39, 3.44) | 2.27 | (1.41, 3.67) | 0.001 | |
| 10–14 y | 59.4 | (41/60) | 1.13 | (0.65, 1.94) | 0.97 | (0.55, 1.70) | 0.92 | |
| > 14 y | 25.7 | (100/389) | 0.27 | (0.19, 0.38) | 0.24 | (0.17, 0.35) | 0.0001 | |
| Gender | Male | 50.5 | (151/229) | 1 | 1 | |||
| Female | 42.5 | (229/539) | 0.73 | (0.55, 0.96) | 0.96 | (0.69, 1.33) | 0.81 | |
OR = odds ratio; CI = confidence interval; AOR = adjusted odds ratio; UPS = polyethylene sheeting; ITPS = insecticide-treated plastic sheeting.
Cohort characteristics post-camp construction and before longitudinal monitoring*
| Largo | Tobanda | |||
|---|---|---|---|---|
| UPS | ITPS | UPS | ITPS | |
| Study population size | 49 | 51 | 67 | 55 |
| Mean age in years (SE) | 2.5 (0.11) | 2.3 (0.13) | 2.0 (0.13) | 2.0 (0.14) |
| Gender: % male | 53 | 57 | 49 | 45 |
| Mean hemoglobin (CI) | 9.3 (8.9, 9.6) | 9.9 (9.6, 10.2) | 9.3 (8.9, 9.7) | 9.6 (9.2, 10.0) |
Pre-exposure to insecticide-treated plastic sheeting (ITPS) was 5–9 months during the establishment of Largo and 3–5 months during the establishment of Tobanda. Surface area coverage in Largo was maximized through lining the interior walls and ceilings but in Tobanda was limited to ceilings and roofs.
UPS = polyethylene sheeting.
Incidence rates and ratios of Plasmodium falciparum infection among control and intervention groups in Largo and Tobanda camps, estimated from the random effects Poisson regression model*
| Number enrolled | Total child days at risk | Average number of days at risk | IR (95% CI) | IRR (95% CI) | % PE (95% CI) | Wald test | Adjusted IRR | Adjusted % PE | Wald test | |
|---|---|---|---|---|---|---|---|---|---|---|
| Largo | ||||||||||
| UPS | 49 | 6801 | 139 | 163 (157–169) | 1 | – | 1 | – | ||
| ITPS | 51 | 8459 | 166 | 63 (52–76) | 0.39 (0.36–0.41) | 61 (59–63) | < 0.001 | 0.40 (0.33–0.47) | 60 (53–67) | < 0.001 |
| Tobanda | ||||||||||
| UPS | 67 | 9102 | 136 | 157 (147–167) | 1 | – | 1 | – | ||
| ITPS | 55 | 6661 | 121 | 133 (120–148) | 0.85 (0.81–0.89) | 15 (11–19) | 0.008 | 0.85 (0.75–0.95) | 15 (5–25) | 0.008 |
IR = incidence rate per 100 child-years at risk; IRR = incidence rate ratio; PE = protective efficacy; UPS = polyethylene sheeting; ITPS = insecticide-treated plastic sheeting; CI = confidence interval.
Adjusted for age and sex.
Figure 4.Kaplan-Meier failure analysis for time to first detected reinfection with Plasmodium falciparum among children 4 months to 3 years of age in (A) Largo refugee camp (ITPS, N = 51; UPS, N = 49) and (B) Tobanda refugee camp (ITPS, N = 55; UPS, N = 67).
Mean (standard deviation) hemoglobin (Hb) levels in child cohorts during cross-sectional surveys after 0, 3, and 6 months of epidemiological monitoring*
| UPS | ITPS | |||
|---|---|---|---|---|
| Mean Hb (g/dl) [sd] | Mean Hb (g/dl) [sd] | |||
| Largo | ||||
| Survey 1 (baseline) | 48 | 9.3a [1.2] | 51 | 9.9a [1.1] |
| Survey 2 (3 months) | 30 | 10.1b [1.0] | 34 | 10.5b [1.2] |
| Survey 3 (6 months) | 19 | 10.0b [1.2] | 21 | 10.6b [1.2] |
| Tobanda | ||||
| Survey 1 (baseline) | 59 | 9.3a [1.4] | 52 | 9.6a [1.5] |
| Survey 2 (3 months) | 36 | 9.1a [1.1] | 29 | 10.3b [1.6] |
| Survey 3 (6 months) | 33 | 9.3a [1.1] | 24 | 10.6b [0.9] |
Values in the same column sharing a superscript do not differ significantly (at P < 0.05 level).
Prospective adverse events (AE) recorded from child cohort longitudinal monitoring visit records between treatment arms*
| Average AE event per child (min-max) | AE events recorded (%) | Total monitoring visits | Phi effect | |||
|---|---|---|---|---|---|---|
| Largo | UPS | 9.6 (0–28) | 498a (10) | 4989 | 0.329 | 0.09 |
| ITPS | 12.4 (2–24) | 596a (11) | 5645 | |||
| Tobanda | UPS | 8.7 (0–27) | 579a (9) | 6118 | 0.699 | 0.04 |
| ITPS | 8.6 (0–21) | 459a (10) | 4740 |
Values in the same column sharing a superscript do not differ significantly (at P < 0.05 level).